title: Changes in the Cytokine and Toll-Like Receptor Gene Expression Following Infection of Indigenous and Commercial Chickens With Infectious bursal disease virus.
abstract: A comparative study of cytokine and toll-like receptor (TLR) mRNA expression in 3 weeks old indigenous and commercial chickens infected with a very virulent strain of Infectious bursal disease virus (IBDV) was performed using a custom-made microarray chip. In uninfected indigenous chickens, the basal levels of interleukin (IL) 15 were lower and IL 16 was higher than their commercial counterparts. In the IBDV infected indigenous chickens, only IL16 gene expression was down regulated, while TLR3 expression was up regulated significantly. In the IBDV infected commercial chickens IL15, IL16 and TLR3 were down regulated. But, IL1-β, IL2, IL8, IL12, IL17, interferon (IFN)-α and β were significantly increased compared with the control. In IBDV infected indigenous chickens, IL15, IFN-γ, beta-defensin and TLR3 were up regulated compared to virus-infected commercial chickens. The results suggested that up regulation of TLR3, a ligand for double-stranded (ds) RNA probably could account for the possible clinical resistance in these birds. There was a 5.2 fold difference by quantitative real-time RT-PCR between indigenous and commercial chickens in TLR3 mRNA expression. Therefore, TLR3, a receptor for dsRNA could be a putative molecule that could play a role in differential innate and adaptive immune responses to IBDV in commercial and indigenous chickens.
authors: Department of Animal Biotechnology, Madras Veterinary College, Tamil Nadu Veterinary and Animal Sciences University, Chennai, 600007 India.
authors: G Dhinakar
authors: GD
authors: Raj
authors: T M Chozhavel
authors: TM
authors: Rajanathan
authors: K
authors: K
authors: Kumanan
authors: S
authors: S
authors: Elankumaran
keywords: Cytokines; Infectious bursal disease virus; Microarray; Real time PCR; Toll-like receptors
references: Trop Anim Health Prod. 1998 Jun;30(3):167-76
references: 9719845
references: Mol Cell. 2006 Jun 9;22(5):561-9
references: 16762830
references: J Biol Chem. 2007 May 25;282(21):15315-8
references: 17395582
references: Proc Natl Acad Sci U S A. 2005 Feb 22;102(8):2992-7
references: 15710891
references: J Immunol. 2006 Feb 1;176(3):1733-40
references: 16424203
references: Arch Virol. 2002;147(2):285-304
references: 11890524
references: J Exp Med. 2003 Feb 3;197(3):343-51
references: 12566418
references: J Virol. 2005 Oct;79(19):12273-9
references: 16160153
references: Vet Res Commun. 1994;18(4):289-93
references: 7831758
references: J Virol. 2003 Jan;77(1):762-8
references: 12477883
references: Trends Immunol. 2005 Sep;26(9):462-8
references: 16027039
references: J Virol. 2004 Aug;78(15):7867-73
references: 15254159
references: Viral Immunol. 2006 Spring;19(1):83-91
references: 16553553
references: J Virol. 2000 Oct;74(19):8884-92
references: 10982331
references: Acta Virol. 2003;47(3):131-5
references: 14658839
references: J Immunol. 1996 Jan 15;156(2):735-41
references: 8543827
references: Vet Immunol Immunopathol. 1998 Feb 27;61(2-4):331-41
references: 9613445
references: Nature. 2007 Oct 18;449(7164):819-26
references: 17943118
references: Viral Immunol. 2006 Summer;19(2):305-15
references: 16817773
references: Mol Immunol. 2006 Feb;43(3):210-25
references: 16199258
references: Dev Comp Immunol. 2004 Feb;28(2):153-62
references: 12969800
references: J Biol Chem. 2005 Feb 18;280(7):5571-80
references: 15579900
references: Virus Res. 2005 Oct;113(1):44-50
references: 15893401
references: Proc Natl Acad Sci U S A. 2003 Feb 4;100(3):1292-7
references: 12552104
references: Vet Immunol Immunopathol. 2001 Oct;82(3-4):229-44
references: 11587737